Skip to main content
. 2025 Mar 3;18(4):sfaf069. doi: 10.1093/ckj/sfaf069

Table 3:

Adverse events related or possibly related to the intervention.

Adverse event Total (n = 23) TRE (n = 10) HE (n = 13)
Hunger 15 (17%) 12 (27%) 3 (7%)
Fatigue 2 (2%) 1 (2%) 1 (2%)
Irritability 5 (6%) 4 (10%) 1 (2%)
Headache 1 (1%) 1 (2%) 0 (0%)
Gastrointestinal distress 11 (13%) 5 (11%) 6 (14%)
Dizziness 1 (1%) 1 (2%) 0 (0%)
Lightheadedness 9 (10%) 5 (11%) 4 (9%)
Electrolyte abnormalities 1 (1%) 1 (2%) 0 (0%)
Other 44 (49%) 15 (33%) 29 (66%)

Data are presented as number of events n (%).